HAVANA TIMES, Feb. 3 – Cuban and Algerian companies agreed to jointly produce hepatitis B vaccines to meet a demand estimated at five million doses a year in that North African country. The agreement signed by Algeria’s Saidal pharmaceutical group and Cuba’s Heber Bistec firm includes the construction of a factory and technological transfer to the Algerian Pasteur Institute, reported IPS.
Israel has ordered 100,000 Palestinians living in eastern Rafah to evacuate ahead of an Israeli…
"Does anyone know how many people in Cuba actually produce value, and how many idlers…
We face discrimination; no one wants to hear what's wrong; everyone wants to hear what's…
In order to improve navigation and features, Havana Times uses cookies.